Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$540M |
| 2 |
Citizens Financial Group
CFG
|
+$304M |
| 3 |
Analog Devices
ADI
|
+$303M |
| 4 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$293M |
| 5 |
Travelers Companies
TRV
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$548M |
| 2 |
Micron Technology
MU
|
+$461M |
| 3 |
Citigroup
C
|
+$334M |
| 4 |
Broadcom
AVGO
|
+$319M |
| 5 |
AbbVie
ABBV
|
+$267M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.23% |
| 2 | Financials | 5.58% |
| 3 | Industrials | 4.98% |
| 4 | Consumer Discretionary | 4.95% |
| 5 | Healthcare | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4576
Calumet Specialty Products
CLMT
$4.19B
| $750K | ﹤0.01% |
89,826
+17,412
| +24% | +$108K |
|
|
ACOR
4577
PUT
DELISTED
Acorda Therapeutics
ACOR
| $750K | ﹤0.01% |
264
-205
| -44% | -$540K |
|
4578
CALL
Silicon Motion
SIMO
$9.12B
| $749K | ﹤0.01% |
15,600
-3,300
| -17% | -$146K |
|
4579
Upland Software
UPLD
$15.7M
| $749K | ﹤0.01% |
+3,541
| New | +$813K |
|
4580
CorVel
CRVL
$3.32B
| $748K | ﹤0.01% |
41,214
+9,513
| +30% | +$159K |
|
4581
PUT
Annaly Capital Management
NLY
$17.6B
| $748K | ﹤0.01% |
15,350
-2,575
| -14% | -$126K |
|
4582
ProShares Ultra Russell2000
UWM
$251M
| $748K | ﹤0.01% |
22,400
-6,232
| -22% | -$188K |
|
|
OME
4583
DELISTED
Omega Protein
OME
| $748K | ﹤0.01% |
44,918
+26,161
| +139% | +$425K |
|
4584
First Citizens BancShares
FCNCA
$25.9B
| $747K | ﹤0.01% |
+1,998
| New | +$715K |
|
|
FLXN
4585
PUT
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $747K | ﹤0.01% |
30,900
-21,100
| -41% | -$496K |
|
4586
PUT
Astec Industries
ASTE
$997M
| $745K | ﹤0.01% |
13,300
+3,900
| +41% | +$199K |
|
|
PDLI
4587
DELISTED
PDL BioPharma, Inc.
PDLI
| $745K | ﹤0.01% |
219,860
-3,439,309
| -94% | -$9.56M |
|
4588
CALL
Brunswick
BC
$5.36B
| $744K | ﹤0.01% |
13,300
-5,200
| -28% | -$292K |
|
4589
PUT
Red Robin
RRGB
$192M
| $744K | ﹤0.01% |
11,100
+600
| +6% | +$36.5K |
|
|
CCMP
4590
PUT
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $743K | ﹤0.01% |
9,300
+3,400
| +58% | +$250K |
|
|
OAK
4591
CALL
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| $743K | ﹤0.01% |
15,800
+8,400
| +114% | +$392K |
|
|
SFE
4592
DELISTED
Safeguard Scientifics, Inc.
SFE
| $742K | ﹤0.01% |
55,577
-541
| -1% | -$6.67K |
|
|
VISN
4593
CALL
Vistance Networks Inc
VISN
$2.66B
| $741K | ﹤0.01% |
22,300
-5,000
| -18% | -$171K |
|
4594
CALL
Enovis
ENOV
$1.5B
| $741K | ﹤0.01% |
10,342
+4,358
| +73% | +$303K |
|
|
BMTC
4595
DELISTED
Bryn Mawr Bank Corp
BMTC
| $741K | ﹤0.01% |
16,926
+2,528
| +18% | +$105K |
|
4596
Brady Corp
BRC
$4.44B
| $740K | ﹤0.01% |
19,502
-25,715
| -57% | -$877K |
|
4597
CALL
iShares US Financials ETF
IYF
$4.43B
| $740K | ﹤0.01% |
13,200
| – | – |
|
4598
CALL
O-I Glass
OI
$1.04B
| $740K | ﹤0.01% |
29,400
+2,400
| +9% | +$58.2K |
|
4599
CALL
Bank OZK
OZK
$5.72B
| $740K | ﹤0.01% |
15,400
-4,200
| -21% | -$187K |
|
|
GPOR
4600
CALL
DELISTED
Gulfport Energy Corp.
GPOR
| $740K | ﹤0.01% |
51,600
-36,600
| -41% | -$475K |
|
Similar funds
Ken Griffin's Q3 2017 Portfolio in Review
As of Q3 2017, Ken Griffin held 8,628 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Ken Griffin's Q3 2017 filing shows 1,223 new, 3,315 increased, 2,707 reduced and 1,164 closed positions. Its largest new stake was Goldman Sachs: 2,394,331 shares worth $568M. The largest sale was Visa, an estimated $548M.
By sector, the portfolio is most concentrated in Technology at 7.2% of assets, down from 7.4% a quarter earlier, followed by Financials and Industrials.
- Ken Griffin's largest Q3 2017 buy was Goldman Sachs: 2,394,331 shares worth $568M.
- Ken Griffin added most to Citizens Financial Group in Q3 2017, an estimated $304M increase.
- Ken Griffin's biggest Q3 2017 reduction was Visa, cutting an estimated $548M.
- Ken Griffin fully exited Citigroup in Q3 2017, selling an estimated $334M.
- Ken Griffin's ten largest holdings make up 17% of its $130B portfolio in Q3 2017.
- Ken Griffin opened 1,223 new positions and closed 1,164 in Q3 2017.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.